Literature DB >> 19122652

Characterization of human embryonic stem cells with features of neoplastic progression.

Tamra E Werbowetski-Ogilvie1, Marc Bossé, Morag Stewart, Angelique Schnerch, Veronica Ramos-Mejia, Anne Rouleau, Tracy Wynder, Mary-Jo Smith, Steve Dingwall, Tim Carter, Christopher Williams, Charles Harris, Joanna Dolling, Christopher Wynder, Doug Boreham, Mickie Bhatia.   

Abstract

Cultured human embryonic stem (hES) cells can acquire genetic and epigenetic changes that make them vulnerable to transformation. As hES cells with cancer-cell characteristics share properties with normal hES cells, such as self-renewal, teratoma formation and the expression of pluripotency markers, they may be misconstrued as superior hES cells with enhanced 'stemness'. We characterize two variant hES cell lines (v-hESC-1 and v-hESC-2) that express pluripotency markers at high levels and do not harbor chromosomal abnormalities by standard cytogenetic measures. We show that the two lines possess some features of neoplastic progression, including a high proliferative capacity, growth-factor independence, a 9- to 20-fold increase in frequency of tumor-initiating cells, niche independence and aberrant lineage specification, although they are not malignant. Array comparative genomic hybridization reveals an amplification at 20q11.1-11.2 in v-hESC-1 and a deletion at 5q34a-5q34b;5q3 and a mosaic gain of chromosome 12 in v-hESC-2. These results emphasize the need for functional characterization to distinguish partially transformed and normal hES cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122652     DOI: 10.1038/nbt.1516

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  32 in total

1.  Preserving the genetic integrity of human embryonic stem cells.

Authors:  Maisam M Mitalipova; Raj R Rao; Deborah M Hoyer; Julie A Johnson; Lorraine F Meisner; Karen L Jones; Stephen Dalton; Steven L Stice
Journal:  Nat Biotechnol       Date:  2005-01       Impact factor: 54.908

2.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Polycomb complexes repress developmental regulators in murine embryonic stem cells.

Authors:  Laurie A Boyer; Kathrin Plath; Julia Zeitlinger; Tobias Brambrink; Lea A Medeiros; Tong Ihn Lee; Stuart S Levine; Marius Wernig; Adriana Tajonar; Mridula K Ray; George W Bell; Arie P Otte; Miguel Vidal; David K Gifford; Richard A Young; Rudolf Jaenisch
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

4.  In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells.

Authors:  M P Imreh; K Gertow; J Cedervall; C Unger; K Holmberg; K Szöke; L Csöregh; G Fried; S Dilber; E Blennow; L Ahrlund-Richter
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

5.  The terminology of teratocarcinomas and teratomas.

Authors:  Ivan Damjanov; Peter W Andrews
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

6.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

7.  Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use.

Authors:  E B Hook
Journal:  Am J Hum Genet       Date:  1977-01       Impact factor: 11.025

8.  Basic fibroblast growth factor support of human embryonic stem cell self-renewal.

Authors:  Mark E Levenstein; Tenneille E Ludwig; Ren-He Xu; Rachel A Llanas; Kaitlyn VanDenHeuvel-Kramer; Daisy Manning; James A Thomson
Journal:  Stem Cells       Date:  2005-11-10       Impact factor: 6.277

9.  Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation.

Authors:  J Inzunza; S Sahlén; K Holmberg; A-M Strömberg; H Teerijoki; E Blennow; O Hovatta; H Malmgren
Journal:  Mol Hum Reprod       Date:  2004-03-25       Impact factor: 4.025

10.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.

Authors:  Sergey V Shmelkov; Jason M Butler; Andrea T Hooper; Adilia Hormigo; Jared Kushner; Till Milde; Ryan St Clair; Muhamed Baljevic; Ian White; David K Jin; Amy Chadburn; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; Gavin Thurston; George D Yancopoulos; Michael D'Angelica; Nancy Kemeny; David Lyden; Shahin Rafii
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more
  98 in total

1.  Efficient generation of nonhuman primate induced pluripotent stem cells.

Authors:  Bonan Zhong; Grant D Trobridge; Xiaobing Zhang; Korashon L Watts; Aravind Ramakrishnan; Martin Wohlfahrt; Jennifer E Adair; Hans-Peter Kiem
Journal:  Stem Cells Dev       Date:  2011-02-01       Impact factor: 3.272

Review 2.  Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology.

Authors:  Rebekah L Gundry; Paul W Burridge; Kenneth R Boheler
Journal:  Proteomics       Date:  2011-09-08       Impact factor: 3.984

3.  Journal club. A cell biologist looks at the risk and promise of a new insight into stem cells and cancer.

Authors:  Paul Knoepfler
Journal:  Nature       Date:  2009-01-22       Impact factor: 49.962

4.  Functional consequences of 17q21.31/WNT3-WNT9B amplification in hPSCs with respect to neural differentiation.

Authors:  Chun-Ting Lee; Raphael M Bendriem; Abigail A Kindberg; Lila T Worden; Melanie P Williams; Tomas Drgon; Barbara S Mallon; Brandon K Harvey; Christopher T Richie; Rebecca S Hamilton; Jia Chen; Stacie L Errico; Shang-Yi A Tsai; George R Uhl; William J Freed
Journal:  Cell Rep       Date:  2015-01-29       Impact factor: 9.423

Review 5.  Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.

Authors:  Chad Tang; Micha Drukker
Journal:  Semin Immunopathol       Date:  2011-04-11       Impact factor: 9.623

Review 6.  Clonal interrogation of stem cells.

Authors:  Kristin Hope; Mickie Bhatia
Journal:  Nat Methods       Date:  2011-04       Impact factor: 28.547

Review 7.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

8.  Safeguarding nonhuman primate iPS cells with suicide genes.

Authors:  Bonan Zhong; Korashon L Watts; Jennifer L Gori; Martin E Wohlfahrt; Joerg Enssle; Jennifer E Adair; Hans-Peter Kiem
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

9.  Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.

Authors:  Hye-Yeong Jo; Youngsun Lee; Hongryul Ahn; Hyeong-Jun Han; Ara Kwon; Bo-Young Kim; Hye-Yeong Ha; Sang Cheol Kim; Jung-Hyun Kim; Yong-Ou Kim; Sun Kim; Soo Kyung Koo; Mi-Hyun Park
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

10.  Chromosome 7 and 19 trisomy in cultured human neural progenitor cells.

Authors:  Dhruv Sareen; Erin McMillan; Allison D Ebert; Brandon C Shelley; Julie A Johnson; Lorraine F Meisner; Clive N Svendsen
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.